Wednesday February 3, 2021
03 Feb 2021 – Destiny Pharma announces Brazilian Patent granted for XF-73 nasal ge...
Destiny Pharma plc (“Destiny Pharma” or “the Company”) Destiny Pharma Announces Brazilian Patent Granted for XF-73 nasal gel preventing post-surgical infections Brighton, United Kingdom – 3rd February 2021 – Destiny […]
Tuesday February 2, 2021
02 Feb 2021 – Destiny Pharma to join panel discussion at the 7th Annual LSX World ...
Destiny Pharma PLC (“Destiny” or “the Company”) Destiny Pharma to Participate in Panel Discussion at the 7th Annual LSX World Congress 2021 Brighton, UK, 2 February 2021 – Destiny Pharma […]
Tuesday February 2, 2021